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Abstract: Hyacinthus orientalis L. (family Hyacinthaceae) is traditionally used to treat different
diseases including cancer. In this study, the anticancer and immunomodulatory effects of this
plant were evaluated. Hydroalcoholic extract was prepared, and different solvent fractions were
obtained using solvent–solvent extraction. In the anticancer part, MTT assay and caspase-3 ELISA
kits were used to measure the antiproliferative and apoptosis induction ability for each extract,
respectively. In the immunomodulatory part, lymphocyte proliferation assay and cytokines detection
kit were used to measure the effect of extracts of acquired immunity. Phagocytosis and pinocytosis
induction were used to evaluate the effect of extracts on the innate immunity. GC–MS, LC–MS,
and Foline–Ciocalteu assays were used to identify the chemical composition of the plant. Balb/C
mice were inoculated with breast cancer and treated with hydroalcoholic extract of H. orientalis L.
Results showed that hydroalcoholic extract and n-hexane fraction were highly effective in apoptosis
induction. Both extract and fraction were also effective in stimulating lymphocytes proliferation and
phagocytosis. Significant reduction in tumor size was achieved after treating tumor-bearing mice
with hydroalcoholic extract. Additionally, high cure percentages (50%) were obtained in treated mice.
Results of this study showed that H. orientalis L. has promising anticancer and immunomodulatory
activities. However, further studies are needed to explore more details of apoptosis induction ability
and other mechanisms of action and to measure different signaling pathways responsible for the
anticancer and immunomodulatory response.
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1. Introduction
Cancer is a leading cause of death worldwide. According to recent World Health
Organization (WHO) reports, cancer is ranked as the first or second leading cause of death
in 172 countries. Estimates for 2018 showed a global cancer incidence of 18.1 million
cases with 9.6 million deaths [1]. Conventional cancer therapies (surgery, radiation, and
chemotherapy) have their disadvantages. The use of chemotherapy is associated with
cancer recurrence, emergence of resistance, and toxicity to the immune system and normal
cells [2]. Therefore, finding new medications with low toxicity and higher activity is a
priority in cancer research.
Plants represent an unlimited source of biologically active natural products that
exhibit high potential to target cancer with relatively limited toxicity. However, the use
of many plant-derived anticancer agents is associated with toxicity and development of
drug resistance. Estimates showed that around 70,000 plant species are used for medical
purposes [3]. Natural products are also gaining significant attention as effective anticancer
agents. Exploring the ability of plants to treat cancer revealed more than 3000 species with
anticancer properties [4]. Currently, more than 60% of anticancer agents originate from
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plants [3]. Examples include vincristine and vinblastine (from Catharanthus roseus), Taxol
(from Taxus brevifolia), Camptothecin (from Camptotheca acuminate), and Harringtonine and
Homoharringtonine (from Cephalotaxus harringtonia) [5]. The anticancer effect of these
natural products is mediated by different mechanisms, including apoptosis induction,
immune system modulation, and angiogenesis inhibition [6].
The use of herbal medicine by cancer patients is a common practice. In the USA,
more than 35% of cancer patients are using herbal medicine with chemotherapy [7]. Additionally, herbal medication is effectively used by cancer patients in the UK for multiple
purposes, such as preventing or relieving some of the direct symptoms of the cancer itself
or dampening down the direct side effects of chemotherapy and radiotherapy used in
the initial treatment process [8]. Despite this, there have only been a limited number of
studies to evaluate the biological activity of a broad spectrum of herbs traditionally used
to treat cancer.
Hyacinthus orientalis L. is an ornamental plant belonging to Hyacinth genus of the
Asparagaceae (formerly, Hyacinthaceae) family. Hyacinth is a small genus of bulbous
herbs native to the Mediterranean region and tropical Africa. Additionally, it is widely
grown in Turkey, France, and the Netherlands [9,10]. In traditional medicine, the whole
plant, leaves, and bulbs of H. orientalis L. were used as hemostatic, for the treatment of
prostate disease and hemorrhoids and wound healing [9]. Although limited studies have
tested the biological activities of this plant [11–14], chemical analysis revealed the presence
of nine acylated anthocyanins in the flowers of H. orientalis L [15]. Anthocyanins are
well-known for their antioxidant, anti-inflammatory, and anti-mutagenesis effects [16]. In
addition, compounds isolated from this plant showed potent inhibitory activity toward
α-glucosidase, and therefore have the potential to be used in the treatment of diabetes [17].
2. Results
2.1. Moisture Content and Percentage Yields of H. orientalis Hydroalcoholic Extract and Fractions
Determination of moisture in powdered plant material revealed that the moisture
content in this plant is 9%. The percentage yield resulted from maceration was 24.3% of
hydroalcoholic extract. On the other hand, fractionation method produced the following
percentages: the highest yield was for aqueous fraction (46%), followed by chloroform
fraction (20.7%), and n-hexane fraction (12%). (Table 1)
Table 1. The percentage yield obtained from the extraction of 2000 gm of H. orientalis using maceration
and solvent fractionation methods (% yield = weight after extraction/weight before extraction * 100%).
Source

Extraction Method

Extraction Solvent

% of Dried Extracts Yields

Maceration

Hydroalcoholic
(ethanol 70%)

24.3%

Chloroform

20.7%

Water

46%

Aqueous/Methanol

6.6%

n-Hexane

12%

H. orientalis
Fractionation

2.2. Antiproliferative Activity of H. orientalis L. Extracts
The effects of various concentrations of H. orientalis L. extracts on the proliferation of
EMT/6, T47D, and MCF-7 cell lines are shown in Figure 1. Hydroalcoholic extract and
chloroform fraction were more cytotoxic against MCF-7 cells with IC5 0 values of 0.95 and
0.70 mg/mL, respectively. However, aqueous methanol and n-hexane fractions exhibited
high activity against T47D cells with IC5 0 values less than 0.7 mg/mL, respectively (Table 2).
Variable degrees of inhibition were observed in MCF-7, T47D, EMT6, and VERO cell lines
with lower toxicity toward VERO cells (Figure 1, Table 2).
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Variable degrees of inhibition were observed in MCF-7, T47D, EMT6, and VERO cell lines
with lower toxicity toward VERO cells (Figure 1, Table 2).
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Table 2. IC₅₀ values of H. orientalis L. extract and fraction against different cell lines.

H. orientalis L. Extracts
Hydroalcoholic extract
IC₅₀ (mg/mL)
Chloroform fraction

MCF-7
Cell Line

T47D
Cell Line

EMT6/P
Cell Line

VERO
Cell Line

0.95 ± 0.07

6.12 ± 0.1

3.65 ± 1.2

>50

0.70 ± 0.2

3.53 ± 0.5

1.53 ± 0.2

>50
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Table 2. IC5 0 values of H. orientalis L. extract and fraction against different cell lines.
H. orientalis L. Extracts

MCF-7
Cell Line

T47D
Cell Line

EMT6/P
Cell Line

VERO
Cell Line

Hydroalcoholic extract
IC5 0 (mg/mL)

0.95 ± 0.07

6.12 ± 0.1

3.65 ± 1.2

>50

Chloroform fraction
IC5 0 (mg/mL)

0.70 ± 0.2

3.53 ± 0.5

1.53 ± 0.2

>50

Aqueous fraction
IC5 0 (mg/mL)

6.59 ± 0.01

11.38 ± 1.2

11.78 ± 0.6

>50

n-hexane fraction
IC5 0 (mg/mL)

2.23 ± 1.5

0.59 ± 0.02

3.65 ± 1.2

>50

Aq. Methanol fraction
IC5 0 (mg/mL)

0.24 ± 0.04

0.11 ± 0.08

3.06 ± 0.5

>50

2.3. Apoptotic Activity of H. orientalis L. Extract and Fractions against T47D Cell Line
Caspase-3 activity assay was used to measure the ability of H. orientalis L. to induce
the programmed cell death. Hydroalcoholic (6.12 mg/mL), chloroform (3.53 mg/mL),
aqueous (11.38 mg/mL), and n-hexane (0.59 mg/mL) significantly enhanced caspase-3
activity. Both hydroalcoholic extract and aqueous fraction enhanced caspase-3 activity by
Plants 2021, 10, x FOR PEER REVIEW3- and 2.5-fold of the negative control, respectively (Figure 2). However, aq. methanol
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treated with 12.5–50 mg/mL H. orientalis L. (Figure 4). At a concentration of
50 mg/mL, the aqueous fraction showed the highest stimulation of peritoneal phagocytic
activity compared to the negative control, followed by aqueous methanol fraction.
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2.7. Effect of H. orientalis L. Extract and Fractions on Cytokines Level
The results demonstrated that there is an increase in IL-2 levels in lymphocytes
with 50 mg/mL of various extract and solvent fractions compared to the negative
control (Figure 6). Hydroalcoholic extract and chloroform fraction induced the highest
increase in IL-2, as well as IFN-γ.
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orientalis
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2.9. LC–MS Analysis
of H. orientalis
Extract
and Fractions
LC–MS analysis showed that trans ferulic acid presented in high percentage in each
LC–MS analysis showed that trans ferulic acid presented in high percentage in each
of n-hexne, chloroform fractions, and hydroalcoholic extract with values of 47.1%, 33.3%,
of n-hexne, chloroform fractions, and hydroalcoholic extract with values of 47.1%, 33.3%,
and 33.2%, respectively. On the other hand, rosmarinic acid was detected abundantly in
and 33.2%, respectively. On the other hand, rosmarinic acid was detected abundantly in
aqueous fraction with percentage value of 78.6%. Additionally, p-coumaric acid was found
aqueous fraction with percentage value of 78.6%. Additionally, p-coumaric acid was
in 30.3% in n-hexane fraction (Table 3). These percentages are relative values depending on
found in 30.3% in n-hexane fraction (Table 3). These percentages are relative values dethe compounds detected in the extract and fractions (Figures S1–S5).
pending on the compounds detected in the extract and fractions (Figures S1–S5).
Table 3. LC–MS analysis results of H. orientalis L. extract and fractions.

Compounds

Formula

RT

Caffeic Acid

C9H8O4

3.31

Relative %
Relative %
Relative % Relative % Relative %
(Hydroalco- (Chloroform (Aq. Metha- (n-hexane (Aqueous
holic Extract) Fraction)
nol Fraction) Fraction) Fraction)
0.35%
0.60%
0.44%
0.00%
1.47%
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Table 3. LC–MS analysis results of H. orientalis L. extract and fractions.

NO

Compounds

Formula

RT

Relative %
(Hydroalcoholic
Extract)

Relative %
(Chloroform
Fraction)

Relative %
(Aq. Methanol
Fraction)

Relative %
(n-hexane
Fraction)

Relative %
(Aqueous
Fraction)

1

Caffeic Acid

C9H8O4

3.31

0.35%

0.60%

0.44%

0.00%

1.47%

2

Vanillin

C8H8O3

3.75

3.16%

1.87%

2.34%

3.18%

0.44%

3

p-Coumaric acid

C9H8O3

4.44

22.74%

18.85%

21.08%

30.31%

0.44%

4

4’-O-GlcA-7-O-GlcA Apigenin (NMR)

C27H26O17

4.66

0.00%

0.01%

0.01%

0.00%

0.16%

5

Ferulic acid (trans)

C10H10O4

5.21

33.21%

33.37%

30.13%

47.17%

0.87%

6

2,4-Dihydroxyacetophenone

C8H8O3

5.21

1.78%

2.16%

2.36%

3.00%

0.04%

7

3-Hydroxy-4-methoxycinnamic acid (isoferulic acid)

C10H10O4

5.66

0.06%

0.04%

0.06%

0.00%

0.28%

8

Luteolin 7-O-glucoside (Cynaroside)

C21H20O11

5.92

3.83%

2.58%

3.37%

5.98%

0.01%

9

Apigenin-7-O-glucoside (Apigetrin)

C21H20O10

6.81

4.46%

2.42%

3.63%

5.42%

0.06%

10

Rosmarinic acid

C18H16O8

7

17.99%

17.30%

23.58%

0.15%

78.67%

11

(4 or 7) Hydroxy-Coumarin Plus Hydrate

C9H6O3

7

2.41%

2.76%

3.99%

0.00%

9.84%

12

3,7,4’-Trihydroxyflavone (5-Deoxykampferol)

C15H10O5

8

0.13%

0.03%

0.09%

0.00%

0.51%

13

3,6,2’,3’-Tetrahydroxyflavone

C15H10O6

8.61

1.63%

2.54%

2.11%

0.13%

3.95%

14

Baicalein

C15H10O5

9.92

2.21%

5.83%

2.61%

0.45%

2.38%

15

Apigenin

C15H10O5

9.93

2.47%

6.09%

3.43%

1.59%

0.97%

16

Galangustin

C17H14O6

10.6

0.10%

0.23%

0.16%

0.01%

0.32%

17

9Z, 11E-Linoleic acid

C18H32O2

29.77

1.49%

0.00%

0.00%

2.60%

0.00%

18

Linoelaidic acid

C18H32O2

30.07

0.00%

3.33%

0.00%

0.00%

0.00%

19

Stearic acid

C18H36O2

32.18

1.99%

0.00%

0.61%

0.00%

0.00%
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2.10. Peganine and Sabinene Are the Main Components of H. orientalis L. Hydroalcoholic Extract
Analysis of the hydroalcoholic extract using GC–MS/MS revealed the presence of
a high concentration of peganine and sabinene with percentages of 25.4% and 19.3%,
respectively (Table 4). Some other compounds found in different concentrations were
limonene (12.3%), ruine (9.5%), linalool (7.1%), myrtenal (6.9%), and alpha-pinene (3.5%).
Table 4. Major compounds identified in the H. orientalis L. hydroalcoholic extract using GC–MS method.
No

Compound

Formula

Molecular Weight (MW)

RT

%

1

alpha-pinene

C10H16

136

9.92

3.5

2

Ruine

C19H22N2O7

390

11.22

9.5

3

Sabinene

C10H16

136

14.83

19.3

4

Peganine

C11H12N2O

188

17.45

25.4

5

Limonene

C10H16

134

19.92

12.3

6

Camphor

C10H16O

152

32.5

6.7

7

Linalool

C10H18O

154

34.99

7.1

8

Myrtenal

C10H14O

150

37.72

6.9

9

Saponin

C97H137NO17Si2

1645

40.02

2.95

10

Quinone

C6H4O2

108

42.61

2.11

GC–MS: Gas chromatography coupled to the tandem mass spectrometry; MW: molecular weight; RT: retention time.

2.11. Toxicity Evaluation of H. orientalis L. Hydroalcoholic Extract
Based on the mortality percentage of the pilot study, the dose of 4000 mg/kg was
selected to be the base dose for LD5 0 determination assay. The LD5 0 was determined
according to the arithmetical method of Karber (Table 5). All mice in group five died, while
only two mice died in group four. No death was observed in groups three and two. The
LD5 0 value of the H. orientalis hydroalcoholic extract was 3000 mg/kg, and as a result the
preliminary therapeutic dose for the in vivo study was 1/10 of the LD5 0 value.
Table 5. Acute toxicity assay of H. orientalis L. hydroalcoholic extract in mice (n = 4) injected intraperitoneally and observed
for 24 h. n = number of mice in each group.
Groups (n = 4)

Dose (mg/kg)

No.
of Mortality

Dose Difference (a)

Mean Mortality (b)

Probit (a × b)

1

PBS +
5% tween 20

0

0

0

0

2

2500

0

0

0

0

3

3000

0

500

0

0

4

4000

2

1000

1

1000

5

5000

4

1000

3

3000

Dose difference (a) = higher dose – lower dose. Mean mortality (b) = (mortality in the second concentration + mortality in the first
concentration)/2.

2.12. Antitumor Effects of H. orientalis L. Hydroalcoholic Extract on EMT6/P Cells Implanted
in Mice
Hydroalcoholic extract was selected to treat tumor bearing mice, as it showed the
highest activity in the in vitro experiments. Treatment of tumor-bearing mice with H.
orientalis L. hydroalcoholic extract showed significant (p < 0.05) reduction of tumor size
(−46.94%) compared to the negative control (107.01%) (Table 6 and Figure 8; Figure 9). The
percentage of mice with no detectable tumor in hydroalcoholic extract-treated group was
50%. In addition, mice exhibited normal activity with no side effects.

entalis L. hydroalcoholic extract showed significant (p < 0.05) reduction of tumor size (46.94%) compared to the negative control (107.01%) (Table 6 and Figure 8; Figure 9). The
percentage of mice with no detectable tumor in hydroalcoholic extract-treated group was
50%. In addition, mice exhibited normal activity with no side effects.
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Final TuTreatment
Initial Tumor
% of Mice with Average Tumor Size % Change in
Table 6. Effect of H.
orientalis L. hydroalcoholic
no Detectable mor Weight
Groups
Size (mm³) ±extract on tumor size and cure percentage.
(mm³) ± Tumor Size
(n = 10)
SEM
Tumor
(g)
Treatment Groups Initial Tumor Size
Final Tumor Size
% Change
% of Mice with no
Average Tumor
SEM in
(n = 10)
(mm3 ) ± SEM
(mm3 ) ± SEM
Tumor
Detectable Tumor
Weight (g)
895.61Size
±
107.01
20%
0.71
Control
432.62 ± 11.1
Control
432.62 ± 11.1
895.61 ± 35.4
107.01
20%
0.71
35.4
H. orientalis hyH. orientalis
252.13
±
hydroalcoholic
475.25 ±droalcoholic
18.4
252.13
± 21.3 ± 18.4
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and
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with H. orientalis resulted in smaller tumors size and higher cure percentage compared to the negative
negative control (n = 10 mice in each group).
control (n = 10 mice in each group).

Discussion
3.3.Discussion
H.orientalis
orientalisL.L.isiswidely
widelyused
usedinintraditional
traditionalmedicine
medicinetototreat
treatdifferent
differentailments.
ailments.The
The
H.
plant
was
traditionally
used
for
prostate
disease,
wound
healing,
and
hemorrhoids.
plant was traditionally used for prostate disease, wound healing, and hemorrhoids. Whole
Whole
plant
leaves
bulbs
were
tested in traditional
different traditional
recipes
In the
curplant
leaves
and
bulbsand
were
tested
in different
recipes [18].
In the[18].
current
study,
rent
study, theand
anticancer
and immunomodulatory
of L.
H. extracts
orientaliswere
L. extracts
were
the
anticancer
immunomodulatory
effects of H. effects
orientalis
evaluated.
evaluated.
The results
the plant
potentialthe
to immune
stimulatesystem
the imThe
results revealed
thatrevealed
the plantthat
exhibits
high exhibits
potentialhigh
to stimulate
and
inhibit
cancer
mune
system
andgrowth.
inhibit cancer growth.
In the antiproliferative assay, all extracts showed various degrees of activity against
cancer cell lines with limited toxicity toward Vero cells. The highest activity was reported
for the aqueous methanol fraction which inhibited cancer cell with concentrations below
0.25 mg/mL and showed limited toxicity against EMT6/P and Vero cell lines. However,
other solvent fractions were also effective at various concentrations against some cell lines.
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In the antiproliferative assay, all extracts showed various degrees of activity against
cancer cell lines with limited toxicity toward Vero cells. The highest activity was reported
for the aqueous methanol fraction which inhibited cancer cell with concentrations below
0.25 mg/mL and showed limited toxicity against EMT6/P and Vero cell lines. However,
other solvent fractions were also effective at various concentrations against some cell lines.
For better understanding of the mechanism of action of these extract and fractions,
apoptosis (programmed cell death) induction was measured using caspase-3 activity assay.
Apoptosis induction is a complex process that can be achieved by two mechanisms: intrinsic
(mitochondrial-dependent) and extrinsic (death receptor-dependent) [19]. The release of
cytochrome c from mitochondria is the starting signal for intrinsic pathway [20], while
binding of ligand to death receptor is the starting signal for extrinsic pathway [21]. Both
pathways end by the activation of caspases and cell death. Caspase-3 is an executioner
caspase activated in both pathways [19], and measurement of its activity after treatment
with extracts is an indication of apoptosis induction. Apoptosis inhibition is one of the
main mechanisms used by cancer cells to secure survival. Thus, induction of apoptosis was
suggested as an effective mechanism to inhibit cancer [22]. Therefore, the extracts were
tested at their IC50 values for their apoptotic effect. The results of this study have shown
that the hydroalcoholic extract had the highest activity. Enhanced caspase-3 activity was
three times higher than the negative control. Other solvent fractions showed moderate to
low apoptosis-inducing effects. The observed apoptosis could be explained by the presence
of high percentage (25.4%) of pegamine in hydroalcoholic extract. This compound was
reported to have apoptosis-induction ability by inhibiting the enzyme topoisomerase I [23].
Another compound that may have participated in apoptosis induction is limonene, which
was also detected in high percentage (12.3%) in the extract. Earlier study has shown that
limonene induces apoptosis by inhibiting PI3K/Akt pathway [24]. Moreover, rosmarinic
acid was detected in high concentration in different extracts of H. orientalis L. It was reported
that rosmarinic acid has the ability to promote cell arrest in the G0 /G1 phase and modulate
the expression of many apoptosis-involved genes [25]. Additionally, trans-ferulic acid was
found at various percentages in four different extracts of H. orientalis L. This compound has
shown antiproliferative activity as well as induced the expression of pro-apoptotic factor
Bax, and reduced the expression of pro-survival factor survivin [26].
Phenolic compounds exhibited anticancer activity. It affects multiple key elements
related to the cell proliferation, apoptosis, angiogenesis, and metastasis [27]. Hydroalcoholic extract and aq. methanol fraction showed high phenolic content compared to the
other fractions.
Human immune system is composed of sophisticated network of cells and organs
that work together to provide protection against different pathogens [28]. In our study,
we evaluated the change in the function of innate and acquired immune response after
treatment with different extract and fractions from H. orientalis L. In the lymphocyte
proliferation assay, the highest response was observed in n-hexane fraction followed by
hydroalcoholic extract. Both activated lymphocyte proliferation in the presence and absence
of mitogens (lipopolysaccharide (LPS) and concanavalin A (Con-A)).
Acquired immune response can be shifted toward T helper-1 (Th1) or T helper-2 (Th2)
response depending on the type of cytokines produced. IL-4 is the key cytokine for Th1
response, while IL-2 and INF-γ is the signature cytokine for Th1 [29]. A balanced ratio of
Th1/Th2 cytokines was observed in healthy individuals. However, a shift in the immune
response toward Th2 was reported in cancer patients [30]. An activation of Th1 immune
response is associated with anticancer immune response [31]. Our results revealed an
increase in the level of IL-2 and INF-γ in lymphocytes treated with the hydroalcoholic
extract. These results indicate a shift in the immune response toward Th1 antitumor
response, which may explain the potent antitumor effect of this extract.
Evaluating the innate immune response showed an effect of this plant in activating
innate immunity. An enhanced macrophage phagocytic activity was observed after treating the cells with increasing concentrations of different fractions. The highest activity
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was reported for the n-hexane fraction. On the other hand, aqueous methanol fraction
showed the highest potential in activating pinocytosis. Both processes (phagocytosis and
pinocytosis) are essential for initiating the antitumor immune response by involving in
antigen presentation to activate T-lymphocytes [32]. The immune stimulating properties
of H. orientalis L. could be the result of specific active compounds present in this plant.
Earlier study has shown that limonene increases phagocytosis in tumor bearing mice [33].
However, when used at a high concentration, it was shown to reduce proliferation of
lymphocytes [34]. It seems that the lymphocytes proliferating effect of H. orientalis L. is due
to the presence of other components in this plant and not due to limonene. Compounds
like saponin, quinone, and rosmarinic acid detected in this plant may have contributed to
the immunomodulatory response by modulating lymphocytes function [35–37].
In the current study, the hydroalcoholic extract of H. orientalis L. was used to treat
mice implanted with breast cancer. Significant reduction in tumor size along with high
cure percentage (50%) were reported. Such regression in tumor size could be a result of the
presence of effective anticancer agents like peganine, limonene, alpha-pinene, saponin, and
quinone. These compounds may work synergistically to inhibit cancer by activating the
immune system and stimulating apoptosis.
Overall, results of this study revealed a promising anticancer effect of extracts obtained
from H. orientalis L. Phytochemicals in this plant work in different anticancer mechanisms
including inhibition of cell proliferation, induction of apoptosis, and modulation of the
acquired and innate immune responses. The study can be further expanded to clearly
understand the mechanisms of action of these extracts and to develop potential anticancer
therapies based on natural products.
4. Materials and Methods
4.1. Animals
Balb/C female mice (4–6-week-old, weight 21–25 g) were used in this study. The environmental conditions in the animal room were: 50–60% humidity, 25 ◦ C with continuous
air ventilation, and alternating light/dark cycles of 12 h. All animal experiments were
evaluated and approved by the Research and Ethical Committee of Applied Science Private
University (Approval Number: 2015-PHA-05). The total number of mice used in this study
was 54 (Table 7).
Table 7. The distribution of mice on different experiments.
No. of Mice

Assessment Study

No. of Mice

Assessment Study

8

Pilot study

20

Anti-tumor assay

20

Acute toxicity assay

6

Immune assay

4.2. Cell lines and Cell Culturing Conditions
Two human epithelial breast cancer cell lines (T47D and MCF-7), mouse mammary cell
line (EMT6/P), and Kidney epithelial cells from African green monkey (Vero) were utilized
to examine the impact of H. orientalis L. extracts against their survival. All cell lines were
provided from The European Collection of Authenticated Cell Cultures (ECACC) (Uk).
The Vero cell line was used as a model of normal cells to measure the toxicity of extracts
in vitro. EMT6/P cells were used to induce breast cancer in mice. These cells were cultured
in the complete medium and incubated at 37 ◦ C in 5% CO2 and 95% humidity incubator.
T47D and MCF-7 cell lines were cultured in complete RPMI 1640 medium, while EMT6/P
was cultured in complete minimum essential medium. Kidney epithelial cells were applied
as normal control and cultured in complete DMEM medium. All culture media were
supplied with 1% L-glutamine, 10% fetal bovine serum, 1% penicillin-streptomycin, and
0.1% gentamycin solution.
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4.3. Plant Collection, Moisture Content, and Extracts Preparation
H. orientalis L. was purchased from the United Arab Emirates market. The taxonomic
identity of the plant was authenticated by botanists in the royal society for the conservation
of nature, Amman, Jordan. Fresh plant was dried at 30 ◦ C with ventilation, powdered
mechanically, and stored in well-closed glass containers in a dry–dark place. Moisture
content was determined using oven-drying method [38]. Briefly, powdered plant material
was weighed and dried in oven at 135 ◦ C for 2 h. The weight was measured again after
drying to calculate the moisture content. Different extracts were prepared by different
solvents. Hydroalcoholic extract was prepared by macerating the plant dried powder
in 70% ethanol (1 L per 100g) in a lab mixer for three days. After that, the extract was
filtered, and the supernatant was concentrated using rotary evaporator. Complete drying
of the extract was performed using lyophilizer, and then the extract was kept at −20 ◦ C
until used. Water, aqueous methanol, chloroform, and n-hexane fractions were prepared
from hydroalcoholic extract using liquid–liquid fractionation method. These solvents were
selected as they help to separate phytochemicals based on their polarity. Hydroalcoholic
extract was subjected to solvent–solvent partitioning between chloroform and water. One
hundred grams of hydroalcoholic extract was mixed with 100 mL chloroform followed
by adding 100 mL water with continuous mixing. The two solvents were loaded in a
separating funnel (250 mL volume) and left to separate overnight. Each solvent was
collected in a clean beaker and the solvents were evaporated using rotary evaporator.
After drying both fractions, the chloroform fraction was also subjected to solvent–solvent
partitioning between n-hexane and aqueous methanol (Figure 10). All the fractions 14
were
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Figure 10. Steps of extract and fractions preparation.
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Cells were incubated with MTT for 3 h followed by adding stop solution. One hour after
adding the stop solution, the developed color was measured using microplate reader. Percentage survival was estimated by comparing the absorbance of treated cells to the nega-
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hour after adding the stop solution, the developed color was measured using microplate
reader. Percentage survival was estimated by comparing the absorbance of treated cells to
the negative control (tissue culture media and 0.1% DMSO). The half maximal inhibitory
concentration (IC5 0) was calculated using non-linear regression in SPSS. The assay was
conducted on three breast cancer cell lines (MCF-7, T47D, and EMT6/P) and one normal
cell line (Vero). Vero cell line was used to determine the toxicity of extracts on normal cells.
4.5. Apoptosis Detection in T47D Cells
T47D cells were cultured in six separated 25 cm2 flasks at a concentration of
150,000 cells/mL of complete tissue culture medium. After 24 h of incubation, the media in
each flask was discarded and the attached cells were treated with H. orientalis L. different
extract and fractions at the IC50 concentration of each extract. Concentrations of the H. orientalis L were as the following: hydroalcoholic (6 mg/mL), chloroform (3.5 mg/mL), aqueous
(11 mg/mL), aqueous methanol (0.1 mg/mL), and n-hexane (0.6 mg/mL). Following incubation for 48 h, media of each flask was removed, and the attached cells were harvested.
Caspase-3 activity was measured according to the kit instructions (caspase-3 assay kit,
Abcam, Cambridge, MA, USA). Briefly, cells were mixed with chilled cell lysis buffer for
10 min followed by centrifugation at 10,000× g for 1 min. Supernatants were aspirated
and DEVD-p-nitroanilide was added to the supernatants as a substrate and incubated for
two hours. Color development was measured at 405 nm using spectrophotometer. Foldincrease in caspase-3 activity was detected by comparing extracts results with the level of
the negative control. Procedure of the assay was carried out as described previously [40].
4.6. Preparation of Murine Splenocytes
Three Balb/C mice were used in this experiment. Mice were sacrificed, and the spleen
was withdrawn under aseptic conditions from each mouse. Spleen cells were moved
through a mesh of a tissue grinder, and the cell suspension was prepared in complete RPMI1640 media. Then the cell suspension was washed thrice for 10 min utilizing complete
RPMI 1640 media and subsequently re-suspended in 5 mL red blood cells lysis buffer
(1 mol/L NH4Cl). Following 10 min, the cells were centrifuged again and re-suspended in
complete RPMI-1640 media. Splenocytes were washed and cell viability was determined
using trypan blue assay.
4.7. Lymphocytes Proliferation Assay
This assay was performed using MTT -based colorimetric assay according to previously described method [41]. Concisely, splenocytes suspension was made in complete
RPMI-1640 solution at the concentration of 2 × 106 cell/mL, and then seeded into 96-well
culture plate in the presence of mitogens. Con A (concanavalin A) (5 µg/mL) and LPS
(lipopolysaccharide) (4 µg/mL) were used as mitogens for T and B lymphocyte, respectively. To each well, 100 µL of different concentrations of H. orientalis L. extract and fractions
(12.5–50 mg/mL) were added (triplicate). Moreover, the negative control contains the same
volume of RPMI-1640 medium. The plate was incubated for 48 h under 5% CO2 and a
humidified atmosphere at 37 ◦ C temperature. Following the 48 h of incubation, 15 µL
MTT solution was added to each well. Then, microplate was incubated for 4 h. After that,
100 µL DMSO was added per well to dissolve the formazan crystals, and the absorbance
was measured at 570 nm using ELISA microplate absorbance reader. Results were demonstrated as a percentage of proliferation (%) compared to the negative control cells. The
same procedure was repeated with the exclusion of the addition of Con A and LPS [42].
4.8. Macrophage Isolation from Peritoneal Fluid
Three Balb/C mice were used in this experiment. Peritoneal macrophages (PEM)
were isolated from peritoneal cavity as mentioned previously [43]. Concisely, PEM were
harvested from 5 Balb/C mice, which were already injected intraperitoneally with 3 mL
of thioglycollate three days before getting euthanized by cervical dislocation. Then, 5 mL
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ice-cold PBS was introduced into the mouse cavity. Mild massaging was applied, and then
fluid was collected and placed in conical tubes carried on ice. Following centrifugation of
the pooled fluid (1000 rpm, 10 min, 4 ◦ C), the resulting pellet of the cells was suspended in
complete RPMI 1640 medium at a density of 2 × 106 cells/well and permitted to adhere
for 3 h at 37 ◦ C in 5% CO2 humidified incubator. After that, non-adherent cells were
washed away with RPMI 1640 medium, then collected for use in different assays outlined
below [44].
4.9. In Vitro Phagocytic Assay (Nitro Blue Tetrazolium (NBT) Reduction Test)
The NBT reduction assay was conducted according to the process of Rainard [45].
Briefly, PEM (5 × 106 cells/well) were cultured in 96-well plate with different concentrations of H. orientalis L. extracts (12.5–50 mg/mL) for 48 h at 37 ◦ C in the incubator.
Consequently, 20 µL yeast suspension (5 × 106 cells/well in PBS) and 20 µL nitro blue
tetrazolium (NBT) (1.5 mg/mL in PBS) were added to each well. Negative controls wells
received 20 µl PBS and 20 µl DMSO. The plate was incubated for 60 min at 37 ◦ C. Afterward,
the supernatant was discarded, and the adherent macrophages were washed with RPMI
1640. The cells were air-dried before 120 µL of 2M KOH and 140 µL DMSO were added to
each well. The absorbance was measured at 570 nm in the microplate reader. Phagocytic
activity was calculated based on the following equation [44]:
Stimulation index = (OD sample − OD control)/OD control * 100
4.10. Determination of Pinocytic Activity Using Neutral Red Method
Peritoneal mice macrophages were seeded into a 96-well plate. H. orientalis L. extract
and fractions were added in three different concentrations (50, 25, and 12.5 mg/mL) and
incubated for 48 h at 37 ◦ C in the incubator. Neutral red solution was prepared (7.5 mg/mL
in PBS), and then added (100 µL) to each well. The plate was incubated for 2 h. Supernatant
was aspirated and the wells were washed with PBS many times to remove the remaining
particles of the neutral red. Cells were disintegrated using cell lysis solution (ethanol
and 0.01% acetic acid at the ratio 1:1), as 100 µL was added to each well and overnight
incubated at room temperature. Microplate reader was used to read the absorbance at
540 nm. Pinocytic activity was expressed as pinocytic index and calculated as described in
the phagocytosis section [45].
4.11. Effect of H. orientalis L. Extracts on Cytokines Levels in Activated Lymphocytes
Murine splenocytes (2 × 106 cells/mL) were cultured with various extracts of H.
orientalis L. (50 mg/mL) for 48 h in CO2 incubator at 37 ◦ C. Levels of IFN-γ, IL-2, IL-4,
and IL-10 were measured using TH1/TH2 ELISA kit (affymetrix ebioscience, Canada).
After period of incubation, supernatants were collected and used to estimate the level of
cytokines according to the standard kit procedure [46]. Based on the calculated standard
curve of each cytokine, absorbance values were converted into concentration (pg/mL).
4.12. Detection of Total Phenolic Content (TPC) Using Folin–Ciocalteu Method
A total content of phenol in H. orientalis L. polar extract and fractiona was determined
according to the procedure demonstrated by Akyuz with some modifications [47]. Samples
were prepared at concentration of 100 mg/mL. In a 96-well plate (flat bottom), 12.5 µL from
the H. orientalis L. was added to each well in triplicate, followed by 250 µL of 2% sodium
carbonate solution. They were left for 5 min at room temperature (RT). Then, 12.5 µL of
50% of Folin–Ciocalteu reagent was added and left for 30 min at RT. Microplate reader
was used to record the absorbance of the mixture at 630 nm. The phenolic content was
estimated as gallic acid equivalents GAE/g of dry weight on the basis of a standard curve
of gallic acid. The standard curve was prepared using gallic acid solution at different
concentrations (0.1–1 mg/mL) in distilled water.
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4.13. LC–MS Measurements of H. orientalis L. Extracts
Samples have been prepared by dissolving them in 2 mL DMSO (dimethyl sulfoxide)
and completed the volume to 50 mL with acetonitrile. Centrifuge of each sample was conducted at 4000 rpm for 2 min, then 1 mL has been transferred to the autosampler. Injection
volume was 3 µL. The analysis was performed using Burker Daltonik (Berman, Germany)
impact II ESI-Q-TOF system equipped with Burker Dalotonik Elute UPLC system (Beremen, Germany). The instrument was operated using the Ion Source Apollo II ion funnel
electrospray source (capillary voltage: 2500 v; nebulizer gas: 2 bar; dry gas flow: 8 L/min;
dry temperature: 200 ◦ C; mass accuracy: less than 1ppm; mass resolution: 50,000 FRS; the
TOF repetition rate: 20 kHz). Chromatographic separation was performed using Burker
solo 2-C-18 UHPLC column (100 mm × 2.1 mm × 2 µm) at flow rate of 0.51 mL/min and a
column temperature of 40 ◦ C. All standards were used for identification of ms/z and the
retention time.
4.14. GC–MS Analysis of H. orientalis L. Hydroalcoholic Extract
Analysis was performed by using GC-2010 plus gas chromatography (Shimadzu,
Tokyo, Japan) coupled to a GCMS-QP 2010 SE mass spectrometry detector (Shimadzu,
Tokyo, Japan) and equipped with an AOC20i auto-injector (Shimadzu, Tokyo, Japan). A
capillary Rtx-5MS column (30 m × 0.25 mm i.d × 0.25 µm film thickness, Restek, Bellefonte,
PA, USA) was used for separation. Helium (at flow rate of 1.0 mL/min) was used as carrier
gas. Temperature was kept at 60 ◦ C for 5 min and set to reach 240 ◦ C at the rate of 3 ◦ C
per min. The samples were injected at a temperature of 250 ◦ C. The injection volume was
1.0 µL in 1:30 split ratio. The mass spectra were acquired with electron impact ionization
(70 Ev) at full scan mode (40 to 500 m/z), utilizing an ion source at 200 ◦ C. The detection
of compounds was achieved using NIST (National Institute of Standards and Technology,
Gaithersburg, MD, USA) mass spectral library.
4.15. Acute Toxicity of H. orientalis L. Hydroalcoholic Extract
This procedure was conducted to determine the toxicity of the extract (hydroalcoholic
extract) on normal mice, which will help to determine the therapeutic dose. A pilot
study was applied on a small group of mice to choose the dose ranges for actual LD5 0
(median lethal dose) determination. Briefly, the hydroalcoholic extract was dissolved in PBS
containing 5% of tween 20. Two female mice (six weeks old, 20–23 g weight) were injected
intraperitoneally with a specific dose of the extract, followed by observation of mortality
for 24 h. The next doses were increased by 1.5 if the dose was tolerated, or reduced by
0.7 if it was lethal using new animals. The maximum non-lethal and minimum lethal
doses represented the lower and upper limits, which were used to prepare LD5 0 doses [48].
For LD5 0 determination, four groups (n = 4) of mice were injected intraperitoneally with
different concentrations (2500, 3000, 4000, and 5000 mg/kg) of the extract within the higher
and lower range detected in the pilot study. The untreated fifth group (n = 4) was used
as a negative control and injected IP with PBS and 5% tween 20. Mice were observed for
24 h for mortality and general behavior. The LD5 0 was indicated by the concentration that
showed 50% mortality applying the arithmetical method of Karber [20].
4.16. Antitumor Activity on Experimental Animals
The mouse mammary tumor cells EMT6/P were harvested by trypsinization and
tested for their viability using trypan blue exclusion method. Twenty Balb/C mice were
injected subcutaneously in the abdominal area with tumor induction dose of 1 × 105
cells in 0.1 mL. After 14 days, the dimensions of the grown tumors were measured using
digital caliper. Then, tumor volumes were measured according to the following formula:
(A × B2 × 0.5), where A was the length of the longest aspect of the tumor and B was the
length of the perpendicular to A [49]. Tumor-bearing mice were set into two groups each
with 10 mice. Group 1 represented the negative control and received daily intraperitoneal
injection (100 µL) of the vehicle (5% tween 20 in PBS). Group 2 was treated with hydroal-
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coholic extract of H. orientalis L. at a dose of 300 mg/kg (10% of the determined LD5 0).
The hydroalcoholic extract was selected for the in vivo antitumor assay, as this extract
represents the main extract used in the first step in the extraction procedure, and all other
fractions were fractionated from hydroalcoholic extract. Additionally, the hydroalcoholic
extract showed moderate to high activity in all in vitro anticancer and immunomodulatory
assays. All treatments were pursued for 10 days, and then tumors were remeasured before mice were sacrificed (using cervical dislocation). Tumors were removed and stored
in 10% formalin.
4.17. Statistical Analysis
Quantitative data were shown as mean ± standard error. The statistical significance
among the groups was carried out by using a one-way analysis of variance (ANOVA) and
student’s t-test. A p-value < 0.05 was considered significant. The IC5 0 values obtained with
the different concentrations of plant extract were calculated using nonlinear regression in
SPSS (Statistical Package for the Social Sciences, Chicago, IL, USA, version 24).
5. Conclusions
H. orientalis L. is a plant with high anticancer and immunomodulatory effects. The
anticancer activity of this plant is mediated by apoptosis induction, while the immunomodulatory effect involves activation of innate and acquired immune responses. Both effects are
the result of the presence of biologically active compounds in the plant extracts. Therefore,
H. orientalis L. can be considered a source of anticancer and immunomodulatory agents.
However, further testing is needed to investigate the chemical composition of this plant
and understand its mechanisms of action, including the ERK or PI3K-Akt/PKB signaling pathways.
Supplementary Materials: The following are available online at https://www.mdpi.com/2223-7747/10
/4/617/s1, Figures S1–S5. LC-MS chromatograms of H. orientalis hydroalcohlic extract and fractions.
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